Scholarlink

<p>Infertility affects 10–15% of couples globally, presenting complex medical and psychosocial challenges. Assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and preimplantation genetic testing (PGT), have revolutionized treatment for conditions like oligospermia, tubal factor infertility, and diminished ovarian reserve. Emerging innovations—such as AI-driven embryo selection, micro-TESE for azoospermia, and in vitro activation (IVA) of follicles—are transforming outcomes for refractory cases. Concurrently, advancements in vitrification and research on the uterine microbiome offer new diagnostic and therapeutic avenues. Despite these strides, infertility’s emotional toll—marked by anxiety, depression, and stigma—often exacerbates physical challenges and may impair treatment success. This review underscores the imperative to integrate ART with psychosocial support systems, including cognitive-behavioral therapy (CBT), mindfulness interventions, and patient-centered counseling. As cutting-edge technologies like CRISPR gene editing and stem cell therapies advance, ethical considerations and equitable access remain critical. The future of infertility management lies in harmonizing technological precision with holistic care to optimize both clinical outcomes and quality of life.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Innovations and challenges in modern infertility treatment: bridging technology and psychosocial care

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月3日

查看全文
  • Ansar Hussain,
  • Musavir Abbas,
  • Zain-ul-Abideen,
  • Ghulam Mustafa,
  • Muhammad Lateef,
  • Abu Mansoor,
  • Yousaf Raza,
  • Ahmad Hayat,
  • Mushtaq Hussain Lashari

摘要

Infertility affects 10–15% of couples globally, presenting complex medical and psychosocial challenges. Assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and preimplantation genetic testing (PGT), have revolutionized treatment for conditions like oligospermia, tubal factor infertility, and diminished ovarian reserve. Emerging innovations—such as AI-driven embryo selection, micro-TESE for azoospermia, and in vitro activation (IVA) of follicles—are transforming outcomes for refractory cases. Concurrently, advancements in vitrification and research on the uterine microbiome offer new diagnostic and therapeutic avenues. Despite these strides, infertility’s emotional toll—marked by anxiety, depression, and stigma—often exacerbates physical challenges and may impair treatment success. This review underscores the imperative to integrate ART with psychosocial support systems, including cognitive-behavioral therapy (CBT), mindfulness interventions, and patient-centered counseling. As cutting-edge technologies like CRISPR gene editing and stem cell therapies advance, ethical considerations and equitable access remain critical. The future of infertility management lies in harmonizing technological precision with holistic care to optimize both clinical outcomes and quality of life.